CRISPR technology is continually improving to make it more specific, but serious consideration should be given to when and how CRISPR is safe for gene editing.
Academic rigor, journalistic flair
Articles on Gene editing
Displaying 1 - 20 of 68 articles
A growing international divide over cutting-edge medical research could worsen predatory practices, medical tourism and health inequality.
CRISPR technology could have momentous effects if it's used to edit genes that will be inherited by future generations. Researchers and ethicists continue to weigh appropriate guidelines.
A ban on clinical trials involving gene editing rules out the controversial procedure done in China. But it also prevents procedures that could offer couples a chance for healthy children without genetic disorders.
Scientists and ethicists have called for a five-year moratorium on editing human genes that will pass on to future generations. Yes, society needs to figure out how to proceed – but is this the best way?
CRISPR gene editing should learn from the Slow Food movement. Scientists must allow time for critical conversations and perfecting of techniques before rewriting the source code of humanity.
Scientists worldwide are calling for a moratorium on gene editing in germline cells. But what is a germline cell? How does it differ from other cells in our body? Why does it matter if we edit them?
Four months ago a researcher claimed he had used the tool CRISPR to edit the genomes of twin girls. Now prominent researchers and ethicists are calling for a temporary halt to this sort of work.
According to current regulations, animals that have been genetically edited, like pigs or cows, are considered drugs. What are the consequences of such rules on American livestock and agriculture?
Imagine a future society where parents can choose the characteristics of their children. Does that turn babies into consumer products., and what choice does the child get?
Researchers in China have produce a world first: gene edited, cloned macaque monkeys. They say such animals will be vital for research on human health – but ethical concerns remain.
A pragmatic approach rather than active concealment is to blame for China's lack of research transparency.
When geneticists create mice with special traits, there is no way to be sure that they will be inherited by the offspring. But a new genetic tool called a gene drive may fix the problem.
Forests in the US face many threats: climate change, invasive species, pests and pathogens. Could genetically engineering trees make these plants more resilient?
Researchers are exploring genetic forms of population control called gene drives that spread traits faster that happens naturally. The goal is to curb mosquito-borne diseases like malaria.
CRISPR babies may be just the beginning. China has a different take than the West on ethics and how to get ahead in business and other endeavors.
Genome editing technology has, and will always have, limits. Limits that are related not to the technology itself but to the intrinsic complexity of the human genome.
Gene editing through CRISPR may have greater consequences than climate change or unleashing the energy of the atom.
In an era of big scientific collaborations, China's renegade actions have hurt its reputation. As international researchers back away, it may be the country's military that ultimately suffers.
Questions abound about whether the scientist who created the first gene edited human beings took shortcuts in the ethical oversight process. But pedantically focusing on protocol misses the point.
Top contributors
-
Merlin Crossley is a Friend of The Conversation.Deputy Vice-Chancellor Academic and Professor of Molecular Biology, UNSW
-
Research Assistant Professor in Biomedical Ethics, National University of Singapore
-
Geneticist and Group Leader, The John Curtin School of Medical Research, Australian National University
-
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
-
Doctoral Student in Biochemistry, University of Washington
-
Senior Lecturer, Queensland University of Technology
-
University Research Professor, Dalhousie University
-
Director of Research and Professor of Pathology, Dalhousie University
-
Ph.D. Candidate in Microbiology and Immunology, Dalhousie University
-
Deputy Director - Centre for Stem Cell Systems and Head of Engagements, Ethics & Policy Program, Stem Cells Australia, University of Melbourne
-
Research Fellow in Biomedical Ethics, University of Melbourne
-
Professor of Bioethics & Medicine, Sydney Health Ethics, University of Sydney
-
Associate Professor, Cumming School of Medicine, University of Calgary
-
Professor of Philosophy, La Trobe University
-
Professor of History and Philosophy, and Deputy Dean Research (Faculty of Arts), University of Adelaide
